Indicative studies focusing on cancer research involve discriminating between Luminal A and other molecular subtypes for breast cancer [241], predicting bladder cancer treatment response [242], IDH1 mutation status for LGG [243], [244], and MGMT methylation status for GBM [245], as well as predicting overall survival for GBM patients [246] and non-disease specific subjects [247]. The gene discussed is MGMT; the disease is glioblastoma.